Related Experiment Video
Updated: Jul 3, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Signaling pathways in medulloblastoma
Fadila Guessous1, Yunqing Li, Roger Abounader
1Department of Neurology, University of Virginia, Charlottesville, Virginia 22908, USA.
Abstract:
Medulloblastoma is the most common brain tumor of childhood. Multiple signaling pathways have been associated with medulloblastoma formation and growth. These include the developmental pathways Hedgehog, (Hh) Notch, and Wnt as well as the receptor tyrosine kinases (RTK) c-Met, erbB2, IGF-R and TrkC, and the oncoprotein Myc. Here we review the involvement of these pathways in medulloblastoma malignancy with a focus on their mode of deregulation, prognostic value, functional effects, cellular and molecular mechanisms of action, and implications for therapy.
Insights
This review examines signaling pathways like Hedgehog, Notch, and Wnt in childhood medulloblastoma. Understanding pathway deregulation is key for targeted therapies against this common pediatric brain tumor.
Area of Science:
- Oncology
- Molecular Biology
- Developmental Biology
Background:
- Medulloblastoma is the most common malignant brain tumor in children.
- Aberrant signaling pathways are implicated in medulloblastoma pathogenesis.
- Key pathways include Hedgehog (Hh), Notch, Wnt, and receptor tyrosine kinases (RTKs).
Purpose of the Study:
- To review the role of critical signaling pathways in medulloblastoma malignancy.
- To focus on pathway deregulation, prognostic value, and therapeutic implications.
Main Methods:
- Literature review of signaling pathways in medulloblastoma.
- Analysis of deregulation, prognostic significance, and functional mechanisms.
- Synthesis of information on therapeutic strategies targeting these pathways.
Main Results:
- Multiple developmental and RTK pathways are frequently deregulated in medulloblastoma.
- Deregulation of these pathways impacts tumor growth, progression, and patient prognosis.
- Specific pathways like Hedgehog and Myc have well-defined roles in medulloblastoma development.
Conclusions:
- Targeting deregulated signaling pathways offers promising therapeutic strategies for medulloblastoma.
- Further research into pathway interactions and resistance mechanisms is crucial.
- Personalized therapy based on specific pathway alterations may improve outcomes.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
